Prevalence of cancer survivors diagnosed within the past 20 years accounts for 6%: a population-based study in Hiroshima, Japan.
For cancer survivorship care planning, we measured population-based 20-year prevalence in Hiroshima, Japan. Twenty-year limited-duration prevalence was calculated as the number of individuals aged 0-99 years alive on 31 December 2021 who had been diagnosed with cancer during 2002-2021. A total of 166 854 survivors of i...